75 results
This report shows analysis of the impact of COVID-19 pandemic and associated response measures on routine childhood immunisation using Australian Immunisation Register data. There was no evidence of...
Attaining high immunisation coverage rates for children with medical conditions is vital. The Royal Children's Hospital (RCH) Immunisation Service has the opportunity to check each inpatient's...
A guide to assist immunization providers with decisions regarding measles vaccination catch-up for the Australian community.
An example from Australia of a resource used post-vaccination to provide information on how to care for common reactions to vaccinations
Background: Vaccination rates have remained steady for a number of years in Australia, however geographical areas of lower vaccine coverage remains a day-to-day challenge. The study explores parental...
Background: To inform national healthcare authorities whether quadrivalent influenza vaccines (QIVs) provide better value for money than trivalent influenza vaccines (TIVs), we assessed the...
Home-based record (HBR) for Australia-New South Wales circa 2017
Home-based record (HBR) for Australia-Queensland circa 2017
Home-based record (HBR) for Australia-SA circa 2014
The role of pharmacists in immunisation and vaccination varies across the world; in some countries pharmacists are primarily involved in ensuring the safe supply and ...
BACKGROUND: Australia introduced universal 7-valent pneumococcal conjugate vaccine (PCV7) from 2005, replaced by 13-valent PCV (PCV13) in 2011, uniquely among high-income countries giving doses at 2,...
In the Lancet Infectious Diseases, Eric Chow and colleagues1 present evidence of remarkable population effectiveness against human papillomavirus (HPV), with virtual eradication of targeted types,...
Background
Bivalent rLP2086 is a recombinant factor H binding protein-based vaccine approved in the USA for prevention of meningococcal serogroup B disease in 10–25-year-olds. We aimed to assess...
INTRODUCTION On-going post-licensure surveillance of adverse events following immunisation (AEFI) is critical to detecting and responding to potentially serious adverse events in a timely manner....
In November 2005, hepatitis A vaccine was funded under the Australian National Immunisation Program for Aboriginal and Torres Strait Islander (Indigenous) children aged 12–24 months in the targeted...
Sequential or co-administration of vaccines has potential to alter the immune response to any of the antigens. Existing literature suggests that prior immunisation of tetanus/diphtheria-containing...
To compare the impact of three strategies for delivering a booster dose of adult-formulated tetanus–diphtheria–pertussis (Tdap) vaccine to adolescents in Australia. These comprise: (i)...
Australia implemented conjugate meningococcal C immunization in
2003 with a single scheduled dose at age 12 months and catch-up for
individuals aged 2–19 years. Several countries have recently...
To assess the performance of SmartVax, a prototypic active monitoring system for adverse events following immunisation (AEFI) using short message service (SMS) text messages and clinical data...
Tremendous progress has been made globally to reduce the contribution of measles to the burden of childhood deaths and measles cases have dramatically decreased with increased two dose...
BACKGROUND: Revised Australian guidelines have been announced under the Renew(®) program to commence screening at 25 years of age with HPV testing in 5-yearly intervals, in 2017. We conducted a...
Parents commonly perceive and report that their child has experienced an AEFI. In this group of parents the subsequent expectation of an AEFI and vaccine safety concerns may be heightened. Further...
Although rare, invasive meningococcal disease remains an important cause of mortality and morbidity in children and young adults. Vaccines have been successfully introduced to help protect against...
A cocooning strategy for pertussis vaccination can be highly effective when partially implemented within maternity hospitals, with information accompanied by a funded vaccine. Mothers were highly...
In The Lancet , Julia Brotherton and colleagues report a decrease in precancerous cervical lesions in girls younger than 18 years after population-wide human papillomavirus (HPV) vaccination in...
Multidose vials (MDVs) for injectable therapeutic agents, including vaccines, pose a risk of infection to injected patients as a result of contamination of the vials. The Australian Government...
Neisseria meningitidis is an important cause of invasive bacterial infection in children worldwide. Although serogroup C meningococcal disease has all but disappeared in the past decade as a direct...
Six years after the initiation of the Australian HPV vaccination programme, the researchers have detected a substantial fall in vaccine-targeted HPV genotypes in vaccinated women; a lower prevalence...
To determine the effect of rotavirus vaccination on rotavirus hospitalisations in children under 5 years of age at The Canberra Hospital, Australian Capital Territory. Methods: Rotavirus...
Highlights
•HPV vaccination in Australia commenced in 2007, and included vaccination of 12–13 year old girls at school and a catch-up for females aged 12–26 years. The catch-up was delivered...
This paper presents results of a study determining the efficacy of a values based approach to changing vaccination attitudes. It reports an evaluation survey of the “I Immunise” campaign,...
Increased febrile reactions in Australian children from one influenza vaccine brand in 2010 diminished confidence in influenza immunisation, highlighting the need for improved vaccine safety...
OBJECTIVE: To evaluate the impact of text message reminders (short messaging service (SMS)) on hepatitis B virus (HBV) vaccination completion among high risk sexual health center...
The national quadrivalent human papillomavirus (4vHPV) vaccination programme was launched in Australia in April, 2007. In this study, the researchers aimed to explore the prevalence of...
The mass media has enormous potential to influence health-related behaviours and perceptions. Much research has focused on how the media frames health issues. This study sought to explore how...
OBJECTIVES: In 2013, the Follow-up and Active Surveillance of Trivalent Influenza Vaccine in Mums (FASTMum) program began using short message service (SMS) to collect adverse event information in...
OBJECTIVE: To estimate influenza and pneumococcal immunisation rates by self-report and validate this with immunisation providers.
METHOD:
A random population telephone survey. This was followed by...
Although the PCV7 has substantially reduced the rates of invasive pneumococcal disease, reports from around the world suggest that the incidence of empyema in children has increased following the...
The optimism generated by scientific breakthroughs often turns to disappointment when applied to the real world of clinical care. It is therefore worth celebrating the extraordinary success of...
BACKGROUND: Trivalent influenza vaccine (TIV) has been recommended for pregnant women in Australia for more than a decade and funded since 2009- yet vaccination coverage remains low. Misperceptions...
BACKGROUND: The desire for evidence-based health policy and practice is well established. Routine population-based health information systems play a fundamental role to inform policy decisions and to...
BackgroundInternet-based surveillance systems provide a novel approach to monitoring infectious diseases. Surveillance systems built on internet data are economically- logistically and...
We linked the Australian Childhood Immunisation Register (ACIR) to South Australian (SA) hospital outcome data in order to evaluate the association between Measles Mumps and Rubella (MMR) and...
The Australian Childhood Immunisation Register (ACIR) was established in 1996 as an opt-out register built on the platform of Medicare- the universal national health insurance scheme. Introduction of...